Pharmacogenetic hypersensitivity to somatropin in a child with severe growth hormone deficiency and MC4R p.V166I variant
Journal of Pediatric Endocrinology and Metabolism · 25.11.2026 · 39 (11) · 1185-1189
DOI: 10.1515/jpem-2026-0165 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, online erschienen am 10.08.2026. Verfasst von Ertugrul Sancak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Selcuk University Faculty of Medicine, Konya, Türkiye. Hauptthemen laut MEDLINE: Dwarfism, Pituitary, Human Growth Hormone, Receptor, Melanocortin, Type 4. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Objectives The melanocortin-4 receptor (MC4R) is a G protein–coupled receptor that regulates energy homeostasis. Pathogenic MC4R variants represent the most common cause of monogenic obesity and are frequently associated with increased linear growth. However, the mechanisms linking MC4R signaling to somatic growth remain incompletely understood. We report a child with severe growth hormone deficiency (GHD) carrying a heterozygous MC4R variant (c.496G>A; p.V166I), in whom recombinant human growth hormone (rhGH) therapy triggered an unexpectedly exaggerated clinical and biochemical response, suggesting a potential pharmacogenetic interaction between MC4R signaling and the GH/IGF-1 axis. Case presentation The male patient was first evaluated at 1 month of age due to micropenis and diagnosed with multiple pituitary hormone deficiencies. At 57 months of age, his height was 97.3 cm (−2.56 SDS) and annual growth velocity was 4.1 cm/year (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology, Selcuk University Faculty of Medicine, Konya, Türkiye.
ORCID-Profile: Ertugrul Sancak, Muammer Büyükinan, Ahmet Fatih Yılmaz, Berna Karslı, Fatma Özgüç Çömlek, Fuat Buğrul
Zitieren
APA
Sancak, E., Büyükinan, M., Yılmaz, A. F., Karslı, B., Çömlek, F. Ö., & Buğrul, F. (2026). Pharmacogenetic hypersensitivity to somatropin in a child with severe growth hormone deficiency and MC4R p.V166I variant. Journal of Pediatric Endocrinology and Metabolism, 39(11), 1185-1189. https://doi.org/10.1515/jpem-2026-0165
Vancouver
Sancak E, Büyükinan M, Yılmaz AF, Karslı B, Çömlek FÖ, Buğrul F. Pharmacogenetic hypersensitivity to somatropin in a child with severe growth hormone deficiency and MC4R p.V166I variant. Journal of Pediatric Endocrinology and Metabolism. 2026;39(11):1185-1189. doi:10.1515/jpem-2026-0165
BibTeX
@article{Sancak2026,
author = {Sancak, Ertugrul and Büyükinan, Muammer and Yılmaz, Ahmet Fatih and Karslı, Berna and Çömlek, Fatma Özgüç and Buğrul, Fuat},
title = {Pharmacogenetic hypersensitivity to somatropin in a child with severe growth hormone deficiency and MC4R p.V166I variant},
journal = {Journal of Pediatric Endocrinology and Metabolism},
year = {2026},
volume = {39},
number = {11},
pages = {1185--1189},
doi = {10.1515/jpem-2026-0165}
}
EUVIMED